-
Something wrong with this record ?
Development of a human vasopressin V1a-receptor antagonist from an evolutionary-related insect neuropeptide
MG. Di Giglio, M. Muttenthaler, K. Harpsøe, Z. Liutkeviciute, P. Keov, T. Eder, T. Rattei, S. Arrowsmith, S. Wray, A. Marek, T. Elbert, PF. Alewood, DE. Gloriam, CW. Gruber,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2011
Free Medical Journals
from 2011
Nature Open Access
from 2011-12-01
PubMed Central
from 2011
Europe PubMed Central
from 2011
ProQuest Central
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Health & Medicine (ProQuest)
from 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2011
Springer Nature OA/Free Journals
from 2011-12-01
PubMed
28145450
DOI
10.1038/srep41002
Knihovny.cz E-resources
- MeSH
- Antidiuretic Hormone Receptor Antagonists isolation & purification metabolism MeSH
- Ants MeSH
- Humans MeSH
- DNA Mutational Analysis MeSH
- Neuropeptides genetics isolation & purification metabolism MeSH
- Receptors, Vasopressin agonists MeSH
- Recombinant Proteins genetics isolation & purification metabolism MeSH
- Amino Acid Substitution MeSH
- Protein Binding MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Characterisation of G protein-coupled receptors (GPCR) relies on the availability of a toolbox of ligands that selectively modulate different functional states of the receptors. To uncover such molecules, we explored a unique strategy for ligand discovery that takes advantage of the evolutionary conservation of the 600-million-year-old oxytocin/vasopressin signalling system. We isolated the insect oxytocin/vasopressin orthologue inotocin from the black garden ant (Lasius niger), identified and cloned its cognate receptor and determined its pharmacological properties on the insect and human oxytocin/vasopressin receptors. Subsequently, we identified a functional dichotomy: inotocin activated the insect inotocin and the human vasopressin V1b receptors, but inhibited the human V1aR. Replacement of Arg8 of inotocin by D-Arg8 led to a potent, stable and competitive V1aR-antagonist ([D-Arg8]-inotocin) with a 3,000-fold binding selectivity for the human V1aR over the other three subtypes, OTR, V1bR and V2R. The Arg8/D-Arg8 ligand-pair was further investigated to gain novel insights into the oxytocin/vasopressin peptide-receptor interaction, which led to the identification of key residues of the receptors that are important for ligand functionality and selectivity. These observations could play an important role for development of oxytocin/vasopressin receptor modulators that would enable clear distinction of the physiological and pathological responses of the individual receptor subtypes.
Institute for Molecular Bioscience The University of Queensland QLD 4072 Brisbane Australia
School of Biomedical Sciences The University of Queensland QLD 4072 Brisbane Australia
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19001327
- 003
- CZ-PrNML
- 005
- 20190108130323.0
- 007
- ta
- 008
- 190107s2017 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/srep41002 $2 doi
- 035 __
- $a (PubMed)28145450
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Di Giglio, Maria Giulia $u Center for Physiology and Pharmacology, Medical University of Vienna, Schwarzspanierstrasse 17, 1090 Vienna, Austria.
- 245 10
- $a Development of a human vasopressin V1a-receptor antagonist from an evolutionary-related insect neuropeptide / $c MG. Di Giglio, M. Muttenthaler, K. Harpsøe, Z. Liutkeviciute, P. Keov, T. Eder, T. Rattei, S. Arrowsmith, S. Wray, A. Marek, T. Elbert, PF. Alewood, DE. Gloriam, CW. Gruber,
- 520 9_
- $a Characterisation of G protein-coupled receptors (GPCR) relies on the availability of a toolbox of ligands that selectively modulate different functional states of the receptors. To uncover such molecules, we explored a unique strategy for ligand discovery that takes advantage of the evolutionary conservation of the 600-million-year-old oxytocin/vasopressin signalling system. We isolated the insect oxytocin/vasopressin orthologue inotocin from the black garden ant (Lasius niger), identified and cloned its cognate receptor and determined its pharmacological properties on the insect and human oxytocin/vasopressin receptors. Subsequently, we identified a functional dichotomy: inotocin activated the insect inotocin and the human vasopressin V1b receptors, but inhibited the human V1aR. Replacement of Arg8 of inotocin by D-Arg8 led to a potent, stable and competitive V1aR-antagonist ([D-Arg8]-inotocin) with a 3,000-fold binding selectivity for the human V1aR over the other three subtypes, OTR, V1bR and V2R. The Arg8/D-Arg8 ligand-pair was further investigated to gain novel insights into the oxytocin/vasopressin peptide-receptor interaction, which led to the identification of key residues of the receptors that are important for ligand functionality and selectivity. These observations could play an important role for development of oxytocin/vasopressin receptor modulators that would enable clear distinction of the physiological and pathological responses of the individual receptor subtypes.
- 650 _2
- $a substituce aminokyselin $7 D019943
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antagonisté antidiuretického hormonu $x izolace a purifikace $x metabolismus $7 D065092
- 650 _2
- $a Formicidae $7 D001000
- 650 _2
- $a mutační analýza DNA $7 D004252
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a neuropeptidy $x genetika $x izolace a purifikace $x metabolismus $7 D009479
- 650 _2
- $a vazba proteinů $7 D011485
- 650 _2
- $a receptory vasopresinů $x agonisté $7 D017483
- 650 _2
- $a rekombinantní proteiny $x genetika $x izolace a purifikace $x metabolismus $7 D011994
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Muttenthaler, Markus $u Institute for Molecular Bioscience, The University of Queensland, QLD 4072 Brisbane, Australia.
- 700 1_
- $a Harpsøe, Kasper $u Department of Drug Design and Pharmacology, University of Copenhagen, Jagtvej 162, 2100 Copenhagen, Denmark.
- 700 1_
- $a Liutkeviciute, Zita $u Center for Physiology and Pharmacology, Medical University of Vienna, Schwarzspanierstrasse 17, 1090 Vienna, Austria.
- 700 1_
- $a Keov, Peter $u School of Biomedical Sciences, The University of Queensland, QLD 4072 Brisbane, Australia.
- 700 1_
- $a Eder, Thomas $u IST Austria (Institute of Science and Technology), Am Campus 1, 3400 Klosterneuburg, Austria. CUBE-Division of Computational Systems Biology, Department of Microbiology and Ecosystem Science, University of Vienna, Althanstrasse 14, 1090 Vienna, Austria.
- 700 1_
- $a Rattei, Thomas $u CUBE-Division of Computational Systems Biology, Department of Microbiology and Ecosystem Science, University of Vienna, Althanstrasse 14, 1090 Vienna, Austria.
- 700 1_
- $a Arrowsmith, Sarah $u Harris-Wellbeing Preterm Birth Research Centre, Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, L69 3BX, United Kingdom.
- 700 1_
- $a Wray, Susan $u Harris-Wellbeing Preterm Birth Research Centre, Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, L69 3BX, United Kingdom.
- 700 1_
- $a Marek, Ales $u Laboratory of Radioisotopes, Institute of Organic Chemistry and Biochemistry CAS, Flemingovo nám. 2, CZ-16610 Prague 6, Czech Republic.
- 700 1_
- $a Elbert, Tomas $u Laboratory of Radioisotopes, Institute of Organic Chemistry and Biochemistry CAS, Flemingovo nám. 2, CZ-16610 Prague 6, Czech Republic.
- 700 1_
- $a Alewood, Paul F $u Institute for Molecular Bioscience, The University of Queensland, QLD 4072 Brisbane, Australia.
- 700 1_
- $a Gloriam, David E $u Department of Drug Design and Pharmacology, University of Copenhagen, Jagtvej 162, 2100 Copenhagen, Denmark.
- 700 1_
- $a Gruber, Christian W $u Center for Physiology and Pharmacology, Medical University of Vienna, Schwarzspanierstrasse 17, 1090 Vienna, Austria. School of Biomedical Sciences, The University of Queensland, QLD 4072 Brisbane, Australia.
- 773 0_
- $w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 7, č. - (2017), s. 41002
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28145450 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190107 $b ABA008
- 991 __
- $a 20190108130524 $b ABA008
- 999 __
- $a ok $b bmc $g 1365211 $s 1039450
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 7 $c - $d 41002 $e 20170201 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
- LZP __
- $a Pubmed-20190107